Bengt Mannervik

Oxford Biomedical Gets $1.2M Grant To Develop Proteomic Toxicity Screening PanelOxford Biomedical Research Inc., a privately held biotechnology company in Rochester Hills, has been awarded a $1,163,600 Phase 2 Small Business Innovation Research Grant by the National Institute of Environmental Health Sciences.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen